Yu-Sang Sabrina Yang Selected Research

Gold

1/2019

Amphiphilic nanoparticle delivery enhances the anticancer efficacy of a TLR7 ligand via local immune activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Sang Sabrina Yang Research Topics

Disease

2	Neoplasms (Cancer) 01/2019 - 12/2018
1	Melanoma (Melanoma, Malignant) 01/2017

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 01/2019 - 01/2017
1	GoldIBA 01/2019
1	n-octanethiolIBA 01/2019
1	AcidsIBA 01/2019
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2019
1	AntigensIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	VaccinesIBA 01/2017

Therapy/Procedure

2	Immunotherapy 01/2019 - 12/2018
1	Subcutaneous Injections 01/2019